https://scholars.lib.ntu.edu.tw/handle/123456789/579746
標題: | Development of an Efficient and Sensitive Chemical Derivatization-Based LC-MS/MS Method for Quantifying Gut Microbiota-Derived Metabolites in Human Plasma and Its Application in Studying Cardiovascular Disease | 作者: | Liao, Hsin-Yu Wang, Chin-Yi Lee, Ching-Hua HSIEN-LI KAO WEI-KAI WU CHING-HUA KUO |
關鍵字: | LC−MS; SCFAs; bile acids; cardiovascular disease; derivatization; gut metabolites | 公開日期: | 2-七月-2021 | 卷: | 20 | 期: | 7 | 起(迄)頁: | 3508 | 來源出版物: | Journal of proteome research | 摘要: | Recently, the gut microbiota has been found to be associated with many diseases, such as inflammatory bowel disease, depression, Parkinson's disease, cancer, metabolic syndrome, and cardiovascular disease (CVD). Among various gut microbiota-derived metabolites (GMs), short-chain fatty acids (SCFAs), bile acids (BAs), and tryptophan (TRP) metabolites are the most frequently discussed metabolites. LC-MS/MS shows advantages in quantifying the levels of metabolites with good sensitivity and selectivity; however, the poor ionization efficiency and polar characteristics of SCFAs make their analysis challenging, especially when analyzing plasma samples with low SCFA concentrations. Moreover, without characteristic fragment ions for unconjugated BAs and different detection ion modes for TRP metabolites and BAs, GM analysis is complex and time-consuming. To overcome these problems, we developed a derivatization method combined with LC-MS/MS to enhance the sensitivity and LC retention of GMs. Through derivatization with 3-nitrophenylhydrazine (3-NPH), 7 SCFAs, 9 bile acids, and 6 tryptophan metabolites can be simultaneously analyzed via separation within 14 min on a reversed-phase C18 column. For accurate quantification, 13C6-3NPH-labeled standards were used as one-to-one internal standards. This derivatization approach was optimized and then validated. We further applied this method to investigate the targeted GM profile in patients with CVD. The results showed a significant reduction in plasma butyrate levels in CVD patients compared with healthy controls, suggesting its potentially protective role in CVD. In summary, this work provides a sensitive and effective LC-MS/MS method for simultaneously quantifying gut microbiota-related metabolites in human plasma, which could benefit various future gut microbiota-related studies. |
URI: | https://scholars.lib.ntu.edu.tw/handle/123456789/579746 | ISSN: | 1535-3893 1535-3907 |
DOI: | 10.1021/acs.jproteome.1c00147 | SDG/關鍵字: | 3 nitrophenylhydrazone; antilipemic agent; bile acid; butyric acid; hemoglobin A1c; high density lipoprotein; hippuric acid; low density lipoprotein; phenylhydrazone derivative; propionic acid; tryptophan; unclassified drug; volatile fatty acid; adult; Ar |
顯示於: | 醫學系 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。